Form 4: Nuvalent CEO Sells Shares Under 10b5-1 Plan

Nuvalent, Inc. President and CEO James Richard Porter sold 30,000 shares of Class A Common Stock for $18.93 per share, and an additional 21,597 shares in multiple transactions at weighted average prices ranging from $98.28 to $103.05, all executed on May 4, 2026, under a pre-arranged 10b5-1 trading plan.

Summary

• James Richard Porter, President and CEO of Nuvalent, Inc., executed a series of stock transactions on May 4, 2026.
• These transactions included the acquisition of 30,000 shares of Class A Common Stock at a price of $18.93 per share.
• Additionally, Porter disposed of a total of 21,597 shares of Class A Common Stock through multiple sales.
• The sales occurred at weighted average prices ranging from $98.28 to $103.05 per share.
• All transactions were conducted under a Rule 10b5-1 trading plan adopted by Porter on December 4, 2025.
• Following these transactions, Porter beneficially owns 324,879 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While the sale of shares by a CEO can sometimes be perceived negatively, the execution under a Rule 10b5-1 plan mitigates concerns about insider trading, suggesting a planned financial maneuver rather than a reaction to negative company performance.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially non-insider trading related activity.
• The CEO acquired 30,000 shares at a specific price point, which could be interpreted as a strategic investment or option exercise.
• The company's stock is trading at prices significantly higher than the acquisition price of the 30,000 shares, suggesting positive market performance since the plan's adoption.

Negatives

• The CEO sold a significant number of shares (21,597) at prices substantially higher than the acquisition price of other shares, potentially indicating a belief that the stock has reached a favorable valuation.
• The weighted average sale prices indicate a range of selling points, with the highest being $103.05.

Risks

• The sale of a substantial number of shares by a key executive could be perceived negatively by the market, potentially signaling a lack of confidence in future price appreciation, despite being executed under a 10b5-1 plan.
• The weighted average sale prices indicate a range of selling points, with the highest being $103.05, which could represent a peak in the stock's recent trading.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The transactions are historical events executed under a pre-defined plan.

Management Comments

• The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025.
• The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) of this Form 4.

Industry Context

StockSavvy.ai notes that Form 4 filings by executives are common for managing personal finances and diversifying holdings. The use of a 10b5-1 plan is a standard practice to mitigate concerns about insider trading, allowing executives to sell shares according to a predetermined schedule or price targets.

Stakeholder Impact

• Shareholders: May interpret the sale of shares by the CEO as a signal, though the 10b5-1 plan provides a degree of reassurance against insider trading concerns. The specific prices at which shares were sold could influence short-term market sentiment.
• Employees: Similar to shareholders, employees with stock options or grants may view the CEO's sales in the context of their own holdings and the company's future prospects.
• Creditors: Unlikely to be directly impacted by this specific transaction.

Next Steps

• The reporting person may provide additional detailed information regarding the specific prices of shares sold upon request from the SEC, Nuvalent, Inc., or any security holder.

Key Dates

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, James Richard Porter, Class A Common Stock, Beneficial Ownership, SEC Filing